FIELD: medicine.
SUBSTANCE: compounds can be used for treatment and prevention of diseases associated with activity of specified enzyme, such as diabetes, obesity, diseases associated with food intake, dyslipidemia and hypertension. In general formula (I) 
, R1 represents methyl, ethyl, cyclopropyl, cyclobutyl, isopropyl, tert-butyl, methoxymethyl, cyclopropyl methoxymethyl, 2-methyl thiazolyl, morpholinyl methyl or phenyl; R2 represents hydrogen, C1-4alkyl or phenyl; R3 represents hydrogen, C1-4alkyl or phenyl; R4 represents phenyl, naphthyl, thiophenyl, quinolyl or piperidyl where phenyl, naphthyl, thiophenyl, quinolyl and piperidyl are optionally substituted with one to three substitutes independently chosen of C1-4alkyl, halogen, C1-4alkoxy, cyano, trifluoromethyl, phenyl, phenyls C1-4alkyl, phenyloxy, oxasolyl and pyridinyl; R5 represents hydrogen, C1-4alkyl, phenyl-C1-4alkyl, C3-6dicloalkyl-C1-4alkyl or aminocarbonylC1-4alkyl.
EFFECT: higher clinical effectiveness.
17 cl, 2 dwg, 72 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ARYLPYRIDINE DERIVATIVES | 2005 |
|
RU2374239C2 |
| INDAZOLONE DERIVATIVES AS 11B-HSD1 INHIBITORS | 2005 |
|
RU2392272C2 |
| TETRAHYDROCINNOLINE DERIVATIVES | 2009 |
|
RU2541533C2 |
| AMINOTETRALINE DERIVATIVES CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND USING THEM IN THERAPY | 2010 |
|
RU2546649C2 |
| DERIVATIVES OF N-(SUBSTITUTED PHENYL)-SULFONAMIDE AS KINASE INHIBITORS | 2017 |
|
RU2753520C2 |
| 3-AMINO-PYRIDINE DERIVATIVES FOR TREATING METABOLIC DISORDERS | 2007 |
|
RU2460729C2 |
| DIHYDROOXAZOLE-2-AMINE DERIVATIVES | 2011 |
|
RU2587512C2 |
| IMIDAZOLYLDINONE DERIVATIVES AS B 11b-HSD1 INHIBITORS | 2009 |
|
RU2538986C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
| BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
